Subscribe
shutterstock_1214634313_piotr_swat
Piotr Swat / Shutterstock.com
24 March 2020GenericsRory O'Neill

Israel imports patented antivirals for treating COVID-19

Israel has approved generic versions of an HIV antiviral owned by  AbbVie for use in treating coronavirus, despite the company still holding patent protection and doubts over its effectiveness.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Costa Rica asks WHO to create voluntary COVID-19 IP pool
26 March 2020   The Costa Rican government has asked the World Health Organization to create a voluntary pool to collect patent rights for technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic.
Big Pharma
EU should buy patent rights for COVID-19 tests, says Greece
7 April 2020   Greece has reportedly suggested that EU member states should jointly buy patent rights for COVID-19 tests and vaccines to ensure rapid distribution across the EU.
Big Pharma
Israel targets Teva over MS drug royalties
12 May 2022   The state of Israel has sued Teva Pharmaceuticals for $100 million over alleged unpaid royalties relating to its multiple sclerosis drug, Copaxone.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

More on this story

Americas
Costa Rica asks WHO to create voluntary COVID-19 IP pool
26 March 2020   The Costa Rican government has asked the World Health Organization to create a voluntary pool to collect patent rights for technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic.
Big Pharma
EU should buy patent rights for COVID-19 tests, says Greece
7 April 2020   Greece has reportedly suggested that EU member states should jointly buy patent rights for COVID-19 tests and vaccines to ensure rapid distribution across the EU.
Big Pharma
Israel targets Teva over MS drug royalties
12 May 2022   The state of Israel has sued Teva Pharmaceuticals for $100 million over alleged unpaid royalties relating to its multiple sclerosis drug, Copaxone.

More on this story

Americas
Costa Rica asks WHO to create voluntary COVID-19 IP pool
26 March 2020   The Costa Rican government has asked the World Health Organization to create a voluntary pool to collect patent rights for technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic.
Big Pharma
EU should buy patent rights for COVID-19 tests, says Greece
7 April 2020   Greece has reportedly suggested that EU member states should jointly buy patent rights for COVID-19 tests and vaccines to ensure rapid distribution across the EU.
Big Pharma
Israel targets Teva over MS drug royalties
12 May 2022   The state of Israel has sued Teva Pharmaceuticals for $100 million over alleged unpaid royalties relating to its multiple sclerosis drug, Copaxone.

More features

Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent